ALLOY THERAPEUTICS

alloy-therapeutics-logo

Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Lexington, Massachusetts.

#SimilarOrganizations #People #Financial #Event #More

ALLOY THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Life Science

Founded:
2017-01-01

Status:
Active

Total Funding:
86.25 M USD

Technology used in webpage:
SPF IPv6 Google Apps For Business Person Schema Cloudflare Hosting Facebook Sharer Cloudflare DNS Pinterest Lorem Ipsum Shutterstock


Similar Organizations

demetrix-logo

Demetrix

Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.


Current Advisors List

fabian-hansen_image

Fabian Hansen Board Member @ Alloy Therapeutics
Board_member

alaa-halawa_image

Alaa Halawa Board Member @ Alloy Therapeutics
Board_member

errik-anderson_image

Errik Anderson Chairman @ Alloy Therapeutics
Board_member
2017-01-01

Current Employees Featured

trier-bryant_image

Trier Bryant
Trier Bryant President of Venture Studio, 82VS @ Alloy Therapeutics
President of Venture Studio, 82VS
2022-07-01

errik-anderson_image

Errik Anderson
Errik Anderson Founder and CEO @ Alloy Therapeutics
Founder and CEO
2017-01-01

richard-shimkets_image

Richard Shimkets
Richard Shimkets SVP Genetics and New Technologies @ Alloy Therapeutics
SVP Genetics and New Technologies
2021-06-01

joshua-brandt_image

Joshua Brandt
Joshua Brandt Associate General Counsel @ Alloy Therapeutics
Associate General Counsel
2021-07-01

Founder


errik-anderson_image

Errik Anderson

Acquisitions List

Date Company Article Price
2021-12-09 deepCDR Biologics deepCDR Biologics acquired by Alloy Therapeutics N/A

Investors List

8vc_image

8VC

8VC investment in Series C - Alloy Therapeutics

bossanova-investimentos_image

Bossanova Investimentos

Bossanova Investimentos investment in Series C - Alloy Therapeutics

gaing_image

Gaingels

Gaingels investment in Series C - Alloy Therapeutics

luma-bio-it_image

Luma Bio-IT

Luma Bio-IT investment in Series C - Alloy Therapeutics

mubadala-ventures_image

Mubadala Capital Ventures

Mubadala Capital Ventures investment in Series C - Alloy Therapeutics

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series C - Alloy Therapeutics

peter-thiel_image

Peter Thiel

Peter Thiel investment in Series C - Alloy Therapeutics

presight-capital_image

Presight Capital

Presight Capital investment in Series C - Alloy Therapeutics

founders-fund_image

Founders Fund

Founders Fund investment in Series C - Alloy Therapeutics

ulysses-diversified-holdings-ulysses_image

Ulysses Diversified Holdings (Ulysses)

Ulysses Diversified Holdings (Ulysses) investment in Series C - Alloy Therapeutics

Investments List

Date Company Article Money raised
2022-06-02 Vernal Biosciences Alloy Therapeutics investment in Venture Round - Vernal Biosciences 21 M USD
2022-04-06 Tegmine Therapeutics Alloy Therapeutics investment in Corporate Round - Tegmine Therapeutics N/A
2022-03-08 Mytide Therapeutics Alloy Therapeutics investment in Series A - Mytide Therapeutics 7 M USD
2022-01-04 Wheeler Bio Alloy Therapeutics investment in Seed Round - Wheeler Bio 14 M USD
2021-07-21 Wheeler Bio Alloy Therapeutics investment in Funding Round - Wheeler Bio N/A
2021-07-12 Vernal Biosciences Alloy Therapeutics investment in Seed Round - Vernal Biosciences N/A

More informations about "Alloy Therapeutics" on Search Engine

Alloy Therapeutics - Crunchbase Investor Profile

Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of โ€ฆSee details»

Alloy Roadmap - Antibodies, TCRs, Bispecifics, Genetic Medicine

Jan 9, 2023 Alloy Therapeutics Unveils 2023 Innovation Roadmap Across Antibodies, TCRs, Bispecifics, and Genetic Medicines. โ€” Alloyโ€™s growing services portfolio reflects โ€ฆSee details»

Alloy Therapeutics Raises $42 Million Series D โ€ฆ

Oct 3, 2022 Alloy Therapeutics, a biotechnology ecosystem company, has closed $42 million in Series D financing led by its existing investors 8VC and Mubadala Cap.See details»

Alloy Therapeutics' Leadership Team - Team members and org โ€ฆ

The Alloy Therapeutics leadership team has a wealth of experience in the biotech industry. The team includes the former President of New Frontier Biologics, the Chairman of the โ€ฆSee details»

Alloy Therapeutics Democratizes Access to Biologics โ€ฆ

Nov 4, 2022 The biotechnology ecosystem company Alloy Therapeutics facilitates affordable, non-exclusive access to the entire drug discovery community, from academic โ€ฆSee details»

Alloy Therapeutics Announces an Expansion of its Antibody โ€ฆ

Apr 26, 2023 Alloy Antibody Discovery Services offers partners a fully integrated workflow to discover therapeutic lead candidates, enabling them to expand their core โ€ฆSee details»

Alloy Therapeutics and Wheeler Bio Announce Preferred โ€ฆ

BOSTON, Nov. 8, 2023 /PRNewswire/ -- Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and โ€ฆSee details»

Alloy Therapeutics to Empower Drug Discovery of โ€ฆ

May 2, 2023 BOSTON-- ( BUSINESS WIRE )--Alloy Therapeutics, a biotechnology ecosystem company, announced it is collaborating with Lundbeck, a global โ€ฆSee details»

Alloy Therapeutics and Wheeler Bio Announce Preferred Service โ€ฆ

Nov 8, 2023 Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), โ€ฆSee details»

Alloy Therapeutics to empower drug discovery of Lundbeckโ€™s โ€ฆ

May 2, 2023 Alloy Therapeutics, a biotechnology ecosystem company, announced it is collaborating with Lundbeck, a global pharmaceutical company specializing in brain โ€ฆSee details»

Alloy Therapeutics Unveils 2023 Innovation Roadmap Across โ€ฆ

Jan 9, 2023 In 2023, 82VS will launch new companies from stealth spanning TCR-mimics, bispecific antibodies, novel monoclonal antibodies, and genetic medicines.See details»

Support Groups - Aging Together

Nov 20, 2023 Provides emotional educational and social support for family and friends caring for older adults facing age-related challenges. Caregiver Support Group (in โ€ฆSee details»

Alloy Therapeutics and Wheeler Bio Announce Preferred Service โ€ฆ

Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced today โ€ฆSee details»

HOME | Neatly Ever After

We are based in Warrenton, Virginia, and serve clients throughout Virginia, Washington, DC, and Maryland. Our team is made up of organizers based in Fauquier County and Fairfax โ€ฆSee details»

Tranquil Motion Therapeutic Massage | Warrenton VA - Facebook

Tranquil Motion Therapeutic Massage, Warrenton, Virginia. 96 likes · 8 were here. Tranquil Motion Therapeutic Massage is the premier location for Deep Tissue, Sports, and โ€ฆSee details»

Virginia CROs - Contract Research Map

Discovery Therapeutics, Inc.โ€™s product pipeline includes adenosine agonists and antagonists for the diagnosis and treatment of cardiovascular disease and FLAP โ€ฆSee details»

Careers - Alloy Therapeutics

ATX-Gxโ„ข Biotech Licensee Discovering Novel Therapeutics. Partnering with Target-Rich Biotech Companies. Democratizing Access for Academic Entrepreneurs.See details»